Enjoy complimentary customisation on priority with our Enterprise License!
The Global Artificial Bone Market size is estimated to grow by USD 208 million at a CAGR of 9.44% between 2023 and 2028. There is an increasing awareness and accessibility to advanced medical treatments which is significantly contributing to the market growth. Some of the major awareness initiatives include healthcare education programs, medical conferences, and scientific publications which have helped to spread awareness about the benefits of artificial bone treatments. Additionally, several rapid advancements in medical technologies, such as biomaterials, imaging techniques, and surgical tools, have resulted in the development of more sophisticated and effective artificial bone products. Therefore, this growing awareness among healthcare professionals and the general public about the availability and benefits of advanced medical treatments, including artificial bone products and advancements in technology is positively impacting the market growth.
To learn more about this report, Request Free Sample
The ceramics segment is estimated to witness significant growth during the forecast period. Ceramics have many potential applications as biomaterials due to their physical and chemical characteristics. Some of the main benefits of the ceramics segment are that they are inert in the human body, and they can be used to replace missing teeth and bones due to their hardness and resistance to abrasion.
Get a glance at the market contribution of various segments View a PDF Sample
The ceramics segment was the largest and was valued at USD 112.60 million in 2018. Another key feature of the ceramic segment is that they are very friction-resistant, which makes them best suitable for replacement materials for joints that are not working properly. Furthermore, some types of ceramics, such as pure aluminum silicates or ceramic-polymer composites are widely utilized in dental prosthetics. Hence, there is an increasing demand for ceramic-polymer composites as they can be a potential alternative to amalgam fillings as the amalgam fillings have toxic effects. Hence, the increasing demand for a ceramic segment for several procedure segments is expected to drive market growth which in turn is expected to fuel the market during the forecast period.
The hospitals segment constitutes the largest share of the market as it serves as the primary healthcare facility for a wide range of medical procedures, including orthopedic surgeries and treatments that require the use of artificial bone implants. As hospitals are the forefront facility which performs orthopedic surgeries and procedures, such as performing orthopedic surgeries and procedures, there is an increasing demand for artificial bone implants in these facilities, which, in turn, is expected to fuel the market growth during the forecast period,
Specialty Clinics Segment
The specialty clinics segment is one of the main end users of the market, especially in medical treatment areas like orthopedics and musculoskeletal healthcare. This segment mainly specializes in specific treatment processes such as diagnosis, treatment, and management of various bone-related conditions and injuries. Specialty clinics that are mainly focused on dedicated orthopedic care, such as orthopedic clinics and sports medicine clinics, are staffed with specialized orthopedic surgeons, sports medicine physicians, and other healthcare professionals who have exquisite knowledge and expertise in treating musculoskeletal conditions. Hence, such an increase in the number of clinics that treat orthopedic treatments is expected to drive the market growth during the forecast period.
For more insights about the market share of various regions View PDF Sample now!
North America is estimated to contribute 43% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. One of the main factors for the significant growth of the market in North America is due to the factors such as the widespread adoption of minimally invasive techniques such as joint reconstruction, fusion procedures, and fractures. Factors such as the growing prevalence of orthopedic disorders and the increased number of orthopedic-related surgeries are also significantly contributing to the market growth in the region. Furthermore. there is an increase in the number of patients as well as prominent established companies specialized in the development of highly biocompatible artificial bone are expected to drive the market growth during the forecast period.
Buy Now Full Report and Discover More
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:
AlloSource: The company offers artificial bone such as AlloSource AlloFuse, delivering safe and reliable allograft-based artificial bone products.
Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.
The market encompasses a diverse range of innovations and treatments for orthopedic conditions, trauma, and degenerative bone diseases. Joint reconstruction surgeries, spinal fusion, and craniomaxillofacial procedures utilize advanced materials mimicking human bone to repair fractures and provide structural support. Artificial bones, incorporating inorganic components, are pivotal in bone grafting procedures and addressing osteoporotic fractures resulting from aging or medical conditions. They play a critical role in trauma and extremities injuries, including sports-related incidents, promoting fracture repair and enhancing patient mobility and comfort. In the medical field, artificial bones undergo rigorous laboratory testing to ensure durability and compatibility. As technology advances, the market continues to expand with new materials and techniques for the effective treatment of degenerative bone diseases, offering patients improved quality of life and functional outcomes.
The increasing prevalence of bone disorders and injuries is a major factor driving the market growth. Factors such as lifestyle changes, the aging population, and sports-related injuries are significantly contributing to the growing incidence of bone-related conditions. Some of the common bone injuries include those injuries from trauma, accidents, or falls. One of the most common artificial bone implants is bone grafts and substitutes which play a crucial role in stabilizing fractures and providing the necessary support for bone healing.
Furthermore, some diseases such as osteoarthritis are also fuelling the rising prevalence of bone disorders. Osteoarthritis is a common degenerative bone disease that causes pain, stiffness, and reduced joint mobility. Hence, the growing prevalence of such diseases is expected to drive the market growth during the forecast period.
The growing use of 3D printing technology in bone implants is a major trend in the market. One of the significant advancements in the markets is the increasing use of 3D printing technology, also known as additive manufacturing which allows for the precise fabrication of patient-specific implants and structures with complex geometries tailored to match individual anatomical requirements.
Moreover, one of the main advantages of 3D printing in the market is that it enables the production of highly customized artificial bone implants by utilizing computer-aided design (CAD) software and layer-by-layer deposition of materials. This technology also helps to generate customized implants that perfectly fit a patient's anatomy. The implant, which is designed using 3D printing, is manufactured based on detailed patient-specific imaging data, resulting in improved implant fit and reducing the risk of implant-related complications. Hence, such advanced benefits are expected to drive the market growth during the forecast period.
High entry barriers for new players are a major challenge restraining the market growth. There is a significant entry barrier for smaller companies to come up with an innovative product to penetrate the market due to the presence of several well-established bigger players already dominating the market. As these prominent players have huge distribution networks and contracts with all the major established hospitals and health centers, it can pose a severe challenge for newer companies to penetrate the market.
Furthermore, customers tend to prefer big, well-established companies more when compared to smaller, newer companies, as these prominent companies have big brand names. As a result, customers tend to show resistance toward newer products. As there is a wide variety of products in the market, the customer always has leniency towards these bigger companies that have a broad portfolio of products with higher brand values, which makes it difficult for emerging players to enter and sustain in the market. Hence such factors are expected to hinder the market growth during the forecast period.
Buy Now Full Report and Discover More
The market research report includes the adoption lifecycle of the market research and growth, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth and forecasting strategies.
Customer Landscape
The market research report provides comprehensive data (region wise segment analysis), with forecasts and estimates in "USD Million" for the period 2024 to 2028, as well as historical data from 2018 to 2022 for the following segments.
You may also interested in below market reports:
The market is at the forefront of biomedical innovation, addressing a spectrum of bone-related disorders and surgical interventions. Dental hospitals and research organizations are advancing bone grafting solutions with materials known for their mechanical strength, osteogenic properties, and biocompatibility. Artificial bones, incorporating inorganic components like metals and calcium phosphate, mimic natural bone mineral for effective regeneration therapies and load-bearing applications. Biodegradable polymers and bioactive glasses enhance biodegradability and osteoconductive properties, vital for bone repair and augmentation procedures. Minimally invasive techniques and personalized medicine are transforming treatments, reducing implant rejection, and improving outcomes in surgeries for fractures, osteoporosis, and sports injuries. As the industry evolves, safety and efficacy remain paramount, driving ongoing development in tissue engineering and drug delivery systems to meet the diverse needs of patients and healthcare providers worldwide.
Market Scope |
|
Report Coverage |
Details |
Page number |
172 |
Base year |
2023 |
Historic period |
2018-2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 9.44% |
Market Growth 2024-2028 |
USD 208 million |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
8.41 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 43% |
Key countries |
US, Germany, UK, China, and Japan |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
Aditus Medical GmbH, AlloSource, Bando Chemical Industries Ltd., Baxter International Inc., Biomatlante SAS, Curasan Inc., Graftys SA, HOYA CORP., Johnson and Johnson Services Inc., Koninklijke DSM NV, Maxigen Biotech Inc., Medtronic Plc, Nuvasive Inc., Orthofix Medical Inc., Shenzhen Mindray BioMedical Electronics Co. Ltd, Smith and Nephew plc, Stryker Corp., Xtant Medical Holdings Inc., Ziacom Medical S.L., and Zimmer Biomet Holdings Inc. |
Market dynamics |
Parent market growth analysis, Market Forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the market forecast period. |
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
View Sample PDF at your Fingertips
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Material
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.